Emerging drugs in pancreatic cancer.

about

Emerging drugs in pancreatic cancer.

Item

http://www.wikidata.org/entity/Q35779283

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Emerging drugs in pancreatic cancer.

@ast

Emerging drugs in pancreatic cancer.

@en

type

Item

label

Emerging drugs in pancreatic cancer.

@ast

Emerging drugs in pancreatic cancer.

@en

prefLabel

Emerging drugs in pancreatic cancer.

@ast

Emerging drugs in pancreatic cancer.

@en

P1476

Emerging drugs in pancreatic cancer.

@en

P2093

David Malka

http://www.w3.org/2001/XMLSchema#string

Michel Ducreux

http://www.w3.org/2001/XMLSchema#string

Valérie Boige

http://www.w3.org/2001/XMLSchema#string

P2860

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors

Cancer statistics, 2002

Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.

A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints.

Chemotherapy for advanced pancreatic cancer.

Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer.

Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicity.

P304

73-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.9.1.73

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15155137

http://www.w3.org/2001/XMLSchema#string

Emerging drugs in pancreatic cancer.

about

Emerging drugs in pancreatic cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698